Guidance Presses Urokinase Drugmakers to Estimate Pathogen Contamination Risk

International Pharmaceutical Regulatory Monitor
A A
The European Medicines Agency is urging manufacturers of urokinase-based drugs to estimate the chances that an individual dose of a product might be contaminated with pathogens.

To View This Article:

Login

Subscribe To International Pharmaceutical Regulatory Monitor

Buy This Article Now

Add this article to your cart for $40.00